Asarina Pharma (Sweden)

Treatment of premenstrual dysphoric disorder with the GABAA receptor modulating steroid antagonist Sepranolone (UC1010)—A randomized controlled trial

Marie Bixo, Karin Ekberg, Inger Sundström Poromaa et al. · Psychoneuroendocrinology · 2017 · 129 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Acceleration of Amyloidosis by Inflammation in the Amyloid-Beta Marmoset Monkey Model of Alzheimer’s Disease

Ingrid H.C.H.M. Philippens, Paul R. Ormel, Guus Baarends et al. · Journal of Alzheimer s Disease · 2016 · 77 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

GR3027 antagonizes GABA_Areceptor-potentiating neurosteroids and restores spatial learning and motor coordination in rats with chronic hyperammonemia and hepatic encephalopathy

Maja Johansson, Ana Agustí, Marta Llansola et al. · American Journal of Physiology-Gastrointestinal and Liver Physiology · 2015 · 74 citations · Full text

Medicine, Neuroscience, Pharmacology +17

A pilot study of golexanolone, a new GABA-A receptor-modulating steroid antagonist, in patients with covert hepatic encephalopathy

Sara Montagnese, Mette Munk Lauridsen, Hendrik Vilstrup et al. · Journal of Hepatology · 2021 · 58 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Incidence of hemorrhagic stroke in the general population: validation of data from The Health Improvement Network

David Gaist, Mari‐Ann Wallander, Antonio González‐Pérez et al. · Pharmacoepidemiology and Drug Safety · 2012 · 52 citations

Medicine, Health Informatics, Neurology +12